Study S002268

A Randomized Latino Semaglutide 2.4mg Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05087342
Acronym: LSS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: TRIPLE
Status: COMPLETED
Enrollment: 119
Start: 2022-12-13
Primary completion: 2024-05-29
Lead sponsor: Loma Linda University
Conditions: Obesity; Obesity; Drug; Overweight or Obesity; Weight Loss; Weight Loss Trajectory; Weight, Body
Interventions: DRUG:Semaglutide 2.4mg; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Assessment of weight loss. [Change between baseline and final study visit, seven months post baseline.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.